Skip to main content
SpringerLink
Log in

Dupilumab wirkt gegen atopische Dermatitis

  • AKTUELLE MEDIZIN_KRITISCH GELESEN
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Schwere allergische Krankheiten müssen oft mit Glukokortikoiden behandelt werden. Als Therapiealternative werden humane monoklonale Antikörper erprobt. Bei der atopischen Dermatitis (AD) zeigt Dupilumab gute Ergebnisse.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Beck LA et al. Dupilamid treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371:130–139

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    D. Reinhardt

Authors
  1. D. Reinhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reinhardt, D. Dupilumab wirkt gegen atopische Dermatitis. MMW - Fortschritte der Medizin 157 (Suppl 1), 34 (2015). https://doi.org/10.1007/s15006-015-2867-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-015-2867-y

Search

Navigation